Vertex Pharmaceuticals Incorporated v. Sumit Nigam Trading as Vertex India Healthcare
Case brief
What is this about?
Madras High Court common order dated 02.01.2025 by Justice Abdul Quddhose allowing (TM) A. Nos.49 & 50 of 2023 filed by Vertex Pharmaceuticals (applicant) against Sumit Nigam trading as Vertex India Health care and another (respondents) in (T) OP (TM) Nos.101 & 102 of 2023. Leave granted to file additional documents to prove long user of the subject trade mark; documents received subject to admission, proof and relevancy; respondents free to object on admissibility and relevancy during trial/cross-examination; mediation feedback awaited; OPs listed on 28.01.2025. Keywords: trade mark original petition, additional documents, leave, admission, proof, relevancy, long user.
What did the court decide?
Leave granted to the applicant to file additional documents; the documents are to be received subject to admission, proof and relevancy, with liberty to the respondents to raise objections as to admissibility and relevancy during trial in cross-examination. OPs posted to 28.01.2025.